$FTLF

Pappas Shannon K. purchased $10K of FTLF (indirect holdings)

Pappas Shannon K. purchased 1,000 indirectly-held shares of FITLIFE BRANDS, INC. (FTLF) at $10.25 on 2026-08-19.

Original reporting
SEC EDGAR · Pappas Shannon K.
Published Aug 21, 2026, 12:38 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 12:45 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$FTLF
Neutral
high confidence
Mentioned
$FTLF
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$FTLFNeutralLow
01

Why it matters

The director's purchase is a routine insider transaction with limited market impact.

02

Market read

Low relevance; the filing provides a new data point but is unlikely to affect trading decisions.

03

What to watch

Potential upcoming FDA approvals or partnership announcements could give the purchase more relevance.

Relevance 3/10Novelty 4/10Timing: today

Background

Form 4 filings disclose insider transactions; they are primary sources for insider activity.

Company-level read

Ticker impact

$FTLFNeutralHigh confidence
Context

Director Shannon Pappas purchased 1,000 shares of FITLIFE BRANDS for $10,250 via a Form 4 filing.

Expected impact

minimal impact; price likely unchanged

Evidence & confidence

The transaction size ($10k) is trivial relative to market cap and typical trading volume.

Market effects

None; the purchase does not affect the broader health‑and‑wellness sector.

None; limited to a single micro‑cap.

None

Counterpoint

Even small insider buys can precede positive developments; monitor for upcoming product launches.

Key entities

  • FITLIFE BRANDS, INC.

    Health‑and‑wellness product company listed under ticker FTLF.

  • Shannon K. Pappas

    Director of FITLIFE BRANDS who made the purchase.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$FTLFMed

FitLife Brands (FTLF) Q2 2026 Earnings Call Transcript

FitLife Brands (FTLF) reported Q2 2026 earnings. Legacy FitLife's gross margin rose to 41.7%, but contribution fell 25.9% to $4.2M. Irwin's revenue hit $14.1M, with Amazon sales growing. The company is improving supply chain, product development, and marketing. SG&A costs dropped 3.8% sequentially. The term loan balance is $36.1M, with $8.6M of debt paid since the Irwin acquisition.

$FTLFMed

FitLife Brands Q2 Earnings Call Highlights

FitLife Brands (NASDAQ:FTLF) reported Q2 call highlights. Irwin direct Amazon sales rose from about $500k monthly in Dec 2025 to about $1m in June 2026, with July comparable to June. Legacy revenue fell 23% YoY to $12.4m; gross margin 41.7%. FitLife is extending Irwin shelf life and launching new products. It paid about $1.5m term-loan, cutting term-loan to $36.1m.

$FTLFMed

FITLIFE BRANDS, INC. (FTLF): Results of Operations and Financial Condition

FITLIFE BRANDS, INC. (FTLF) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FitLife Brands Announces Second Quarter 2026 Results OMAHA, NE – August 13, 2026 – FitLife Brands, Inc. (“ FitLife ” or the “ Company ”) (NASDAQ: FTLF), a provider of innovative and proprietary nutritional supplements and wellness products, today announced financial